Details of the Drug Reposition

General Information of This Drug (ID: DMTWKVH)

Drug Name
NAM-NK cells   DMTWKVH
Drug Type
Cell therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Multiple myeloma DISEWP9B 2A83 Phase 1 [1]
Non-hodgkin lymphoma DISS2Y8A 2B33.5 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03019666) Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL. U.S. National Institutes of Health.